Skip to main content
Erschienen in: Annals of Hematology 6/2010

01.06.2010 | Original Article

Bone marrow examination: a prospective survey on factors associated with pain

verfasst von: Christian Degen, Susanne Christen, Alicia Rovo, Alois Gratwohl

Erschienen in: Annals of Hematology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Bone marrow examination (BME) represents an essential tool for diagnosis and monitoring of haematological disorders. It remains associated with morbidity and discomfort; repeat examinations are frequent. We made a single-centre prospective survey on 700 BME between July 2007 and July 2008 with a structured anonymized questionnaire for patients undergoing and physicians performing BME, which includes at our institution always aspiration and trephine. All procedures were performed according to institutionalised standard operating procedures; 412 patients' (58.9%) and 554 physicians' (79.1%) questionnaires were returned. Pain was the only procedure-related complication; no pain was reported in 149 (36.7%), bearable pain in 242 (59.6%) and unbearable pain in 15 (3.7%) cases. Premedication associated complications were reported by 110 (32.7%) of the 336 (65.4%) patients with premedication before BME. None of these were > WHO grade 2; most frequently reported were tiredness (76 patients; 22.6%), dizziness (19 patients; 5.7%) and nausea (15 patients; 4.5%). Only two factors were significantly associated with unbearable pain: “pain during prior BME” (seven of 94 with versus one of 198 without previous pain; p < 0.01) and “information before BME” (four of 11 without versus 12 of 372 with adequate information before BME; p < 0.01). Inadequate information at any time showed a trend towards an association with unbearable pain (p = 0.08). No other factor was associated with unbearable pain. Good and adequate information appears to be the best way to reduce pain, even for a future BME.
Literatur
1.
2.
Zurück zum Zitat Bain BJ (2004) Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 26:315–318CrossRefPubMed Bain BJ (2004) Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 26:315–318CrossRefPubMed
3.
4.
Zurück zum Zitat Bain BJ (2006) Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica 91(9):1293–1294PubMed Bain BJ (2006) Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica 91(9):1293–1294PubMed
5.
Zurück zum Zitat Kuball J, Schüz J, Gamm H, Weber M (2004) Bone marrow punctures and pain. Acute Pain 6:9–14CrossRef Kuball J, Schüz J, Gamm H, Weber M (2004) Bone marrow punctures and pain. Acute Pain 6:9–14CrossRef
6.
Zurück zum Zitat Vanhelleputte P, Kristel N, Delforge M, Evers G, Vanderschueren S (2003) Pain during bone marrow aspiration: prevalence and prevention. J Pain Symptom Manage 26:860–866CrossRefPubMed Vanhelleputte P, Kristel N, Delforge M, Evers G, Vanderschueren S (2003) Pain during bone marrow aspiration: prevalence and prevention. J Pain Symptom Manage 26:860–866CrossRefPubMed
7.
Zurück zum Zitat Wolanskyj AP, Schroeder G, Wilson PR (2000) A randomized placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. Clin Lymphoma 1:154–157CrossRefPubMed Wolanskyj AP, Schroeder G, Wilson PR (2000) A randomized placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. Clin Lymphoma 1:154–157CrossRefPubMed
8.
Zurück zum Zitat Giannoutsos I, Grech H, Maboreke T, Morgenstern G (2004) Performing bone marrow biopsies with or without sedation: a comparison. Clin Lab Haem 26:201–204CrossRef Giannoutsos I, Grech H, Maboreke T, Morgenstern G (2004) Performing bone marrow biopsies with or without sedation: a comparison. Clin Lab Haem 26:201–204CrossRef
9.
Zurück zum Zitat Park SH, Bang SM, Nam E, Cho EK, Shin DB, Lee JH, Ahn JY (2008) A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy. Pain Medicine 9(2):249–252CrossRefPubMed Park SH, Bang SM, Nam E, Cho EK, Shin DB, Lee JH, Ahn JY (2008) A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy. Pain Medicine 9(2):249–252CrossRefPubMed
10.
Zurück zum Zitat Milligan DW, Howard MR, Judd A (1987) Premedication with Lorazepam before bone marrow biopsy. J Clin Pathol 40:696–698CrossRefPubMed Milligan DW, Howard MR, Judd A (1987) Premedication with Lorazepam before bone marrow biopsy. J Clin Pathol 40:696–698CrossRefPubMed
11.
Zurück zum Zitat Sandler ES, Weyman C, Conner K, Reilly K, Dickson N, Luzins J, McGkorray S (1992) Midazolam versus fentanyl as premedication for painful procedures in children with cancer. Pediatrics 89:631–634PubMed Sandler ES, Weyman C, Conner K, Reilly K, Dickson N, Luzins J, McGkorray S (1992) Midazolam versus fentanyl as premedication for painful procedures in children with cancer. Pediatrics 89:631–634PubMed
12.
Zurück zum Zitat Burkle C, Harrison B, Koenig F, Decker P, Warner D, Gastineau D (2004) Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. Am J Hematol 77:250–256CrossRefPubMed Burkle C, Harrison B, Koenig F, Decker P, Warner D, Gastineau D (2004) Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. Am J Hematol 77:250–256CrossRefPubMed
13.
Zurück zum Zitat Pellier I, Monrigal J, le Moine P, Rod B, Railland X, Granry JC (1999) Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study. Paediatr Anaesth 9:61–68CrossRefPubMed Pellier I, Monrigal J, le Moine P, Rod B, Railland X, Granry JC (1999) Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study. Paediatr Anaesth 9:61–68CrossRefPubMed
14.
Zurück zum Zitat Chakupurakal G, Delgado J, Nikolousis E, Pitchapillai S, Allotey D, Holder K, Bratby L, de la Rue J, Milligan DW (2008) Midazolam in conjunction with local anaesthesia is superior to Entonox in providing pain relief during bone marrow aspirate and trephine biopsy. J Clin Pathol 61:1051–1054CrossRefPubMed Chakupurakal G, Delgado J, Nikolousis E, Pitchapillai S, Allotey D, Holder K, Bratby L, de la Rue J, Milligan DW (2008) Midazolam in conjunction with local anaesthesia is superior to Entonox in providing pain relief during bone marrow aspirate and trephine biopsy. J Clin Pathol 61:1051–1054CrossRefPubMed
15.
Zurück zum Zitat Dunlop TJ, Deen C, Lind S, Voyle RJ, Prichard JG (1999) Use of combined oral narvotic and benzodiazepine for control of pain associated with bone marrow examination. South Med J 92(5):477–480CrossRefPubMed Dunlop TJ, Deen C, Lind S, Voyle RJ, Prichard JG (1999) Use of combined oral narvotic and benzodiazepine for control of pain associated with bone marrow examination. South Med J 92(5):477–480CrossRefPubMed
16.
Zurück zum Zitat Bortz J, Lienert GA, Boehnke K (2000) Verteilungsfreie Methoden in der Biostatistik 2. Auflage. Springer, Berlin Bortz J, Lienert GA, Boehnke K (2000) Verteilungsfreie Methoden in der Biostatistik 2. Auflage. Springer, Berlin
Metadaten
Titel
Bone marrow examination: a prospective survey on factors associated with pain
verfasst von
Christian Degen
Susanne Christen
Alicia Rovo
Alois Gratwohl
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 6/2010
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-0934-0

Weitere Artikel der Ausgabe 6/2010

Annals of Hematology 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.